A carregar...
Community Clinical Practice Patterns and Mortality in Patients with Oncotype DX Intermediate Score: Who benefits from Chemotherapy?
BACKGROUND: Oncotype DX recurrence score (RS) is used as a tool for making decision about chemotherapy in hormone receptor-positive, HER2-negative breast cancer. There is no benefit of chemotherapy in node negative, RS 11–25, age ≥50 patients but the benefit of chemotherapy in the node positive grou...
Na minha lista:
| Publicado no: | Cancer |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6329644/ https://ncbi.nlm.nih.gov/pubmed/30387876 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.31818 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|